Matthew I. Gross,Mark K. Bennett,Christopher Molineaux
申请号：
US15085451
公开号：
US20160287564A1
申请日:
2016.03.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
In some aspects, the invention relates to a method of treating cancer, a myeloproliferative disease, an immunological disease, a neurological disease, or a viral infection, comprising orally administering a compound of formula I, formula II, formula III, formula IV, formula V, and/or formula VI, wherein the compound is administered with a meal (e.g., with food as defined herein) or in fed mode.
